Inhibiting the stringent response blocks Mycobacterium tuberculosis entry into quiescence and reduces persistence

Sci Adv. 2019 Mar 20;5(3):eaav2104. doi: 10.1126/sciadv.aav2104. eCollection 2019 Mar.

Abstract

The stringent response enables Mycobacterium tuberculosis (Mtb) to shut down its replication and metabolism under various stresses. Here we show that Mtb lacking the stringent response enzyme RelMtb was unable to slow its replication rate during nutrient starvation. Metabolomics analysis revealed that the nutrient-starved relMtb -deficient strain had increased metabolism similar to that of exponentially growing wild-type bacteria in nutrient-rich broth, consistent with an inability to enter quiescence. Deficiency of relMtb increased the susceptibility of mutant bacteria to killing by isoniazid during nutrient starvation and in the lungs of chronically infected mice. We screened a pharmaceutical library of over 2 million compounds for inhibitors of RelMtb and showed that the lead compound X9 was able to directly kill nutrient-starved M. tuberculosis and enhanced the killing activity of isoniazid. Inhibition of RelMtb is a promising approach to target M. tuberculosis persisters, with the potential to shorten the duration of TB treatment.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Bacterial Proteins / antagonists & inhibitors
  • Bacterial Proteins / chemistry
  • Bacterial Proteins / genetics*
  • Crystallography, X-Ray
  • DNA Replication / drug effects
  • Escherichia coli Proteins / antagonists & inhibitors
  • Escherichia coli Proteins / chemistry
  • GTP Pyrophosphokinase / antagonists & inhibitors
  • GTP Pyrophosphokinase / chemistry
  • Humans
  • Intracellular Signaling Peptides and Proteins / antagonists & inhibitors*
  • Intracellular Signaling Peptides and Proteins / chemistry
  • Intracellular Signaling Peptides and Proteins / genetics
  • Isoniazid / chemistry
  • Isoniazid / pharmacology
  • Mice
  • Mycobacterium tuberculosis / chemistry
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / genetics
  • Mycobacterium tuberculosis / pathogenicity
  • Protein Conformation
  • Small Molecule Libraries / chemistry
  • Small Molecule Libraries / pharmacology
  • Tuberculosis / drug therapy
  • Tuberculosis / genetics*
  • Tuberculosis / microbiology
  • Tuberculosis / pathology

Substances

  • Bacterial Proteins
  • Escherichia coli Proteins
  • Intracellular Signaling Peptides and Proteins
  • RshA protein, Mycobacterium tuberculosis
  • Small Molecule Libraries
  • GTP Pyrophosphokinase
  • relA protein, E coli
  • Isoniazid